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Abstract 
Background: Approximately 9-10 percent of adults experience chronic cough. Chronic cough is 
a cough that lasts greater than eight weeks, with significant impacts on an individual's quality-of-
life in social, psychological, and physical domains. Current treatment is not successful for all 
patients, and a lack of validated outcome measures makes it challenging to determine the 
efficacy of experimental chronic cough interventions. 
Aims: The purpose of this review is to determine the optimal protocols for outcome measures 
needed to ascertain the efficacy of chronic cough treatment. 
Main contribution: Inconsistent correlations were found between objective and subjective 
outcome measures. The strongest outcome measure correlations were found between cough-
specific quality-of-life questionnaires and objective cough frequency counting. Methods of 
objective measures vary and require further investigation. 
Conclusions: Data from both subjective and objective outcome measures are needed to 
determine a cough treatment's efficacy due to the different constructs measured by each tool, and 
the inconsistent correlations found between subjective and objective outcome measures. 
Additionally, further standardization is needed for subjective outcome tools. 
Keywords: chronic cough, outcome measures, treatment efficacy 
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Introduction 
  Cough is a common respiratory complaint for which patients seek medical attention, with 
a significant portion of health-care dollars spent annually to alleviate cough symptoms (Chung et 
al., 2003; Irwin et al., 1998; Lee & Birring, 2012). Typically, coughing serves as a defense 
mechanism from the inhalation of unwanted or harmful agents and excess secretions into the 
airway (Hsu et al., 1994; Irwin et al., 1998; McGarvey & Gibson, 2019). The cough is a visceral 
reflex tied to the afferent vagal nerve (cranial nerve X), with higher cortical control. This 
arrangement allows the cough mechanism to be both voluntary and involuntary (Irwin et al., 
2006). A cough is typically comprised of three phases; an initial inspiratory stage, the 
compressive phase, and the explosive phase (McGarvey & Gibson, 2019; Pramono, Imtiaz, & 
Rodriguez-Villegas, 2016). 
 Chronic cough is a cough that lasts greater than eight weeks and is reported by 9-10% of 
adults (Lee & Birring, 2012; Song et al. 2015). Chronic cough can have significant impacts on 
quality-of-life in social, psychological, and physical domains (Morice, McGarvey & Povard, 
2006; Vertigan, Theodoros, Gibson & Winkworth, 2006). It may lead to mild troubles such as 
hoarse voice, sleep disturbance, chest pain, self-consciousness or more severe disturbances such 
as stress urinary incontinence, abdominal muscle ruptures, or loss of consciousness (Irwin et al., 
1998; Morice et al., 2006; French, Fletcher, & Irwin, 2006). Patients with chronic cough may 
cough anywhere from one hundred to one thousand times per day, with Hsu et al. (1994) finding 
that patients coughed an average of 794 times in a day, ranging from 64-3,639 coughs per 
participant. 
  Chronic cough may have several etiologies, including respiratory conditions and non-
respiratory conditions. Respiratory conditions include asthma, upper airway disease, 
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gastroesophageal reflux disease (GORD), and chronic obstructive pulmonary disease (COPD). 
Non-respiratory conditions may consist of rhinosinusitis and gastroesophageal reflux (Morice et 
al., 2006; Irwin et al., 2006; Smith & Woodcock, 2017). Clinicians utilize client medical history, 
clinical examination, spirometry, and chest radiography or high resolution computed 
tomographic scanning of the thorax to identify or eliminate conditions that may underlie the 
patient's cough (Lee & Birring, 2012; Morice et al., 2006; Smith & Woodcock, 2017). When 
cough persists despite appropriate investigation and treatment, it is termed idiopathic (ICC) or 
unexplained (UCC), meaning cough with no underlying diagnosable condition. A cough that 
persists despite best treatment for the assumed associated conditions is termed refractory chronic 
cough (RCC) (Irwin et al., 2006; McGarvey & Gibson, 2019). In specialty pulmonary clinics, 
between 20-42% of patients experience unexplained cough (Morice et al., 2006; Vertigan, 
Theodoros, Gibson & Winkworth, 2006). 
  Chronic cough is difficult to treat due to the multiplicity of possible underlying 
conditions or causes, with treatment effectiveness varying by etiology. Because underlying 
diagnoses remain unknown for many patients, targeted intervention is not always effective or 
feasible. As researchers continue to investigate medical treatment and alternative management of 
chronic cough, they rely on multiple measures (subjective and objective) to assess cough and 
describe treatment outcomes for patients. Subjective outcome measures are outcome measures 
that collect data from patient self-report. Objective outcome measures are instruments that 
collect data independent of the patient's experience. While objective measures are the gold 
standard to determine efficacy for clinical trials, they may be limited to a laboratory setting and 
time consuming (Nguyen, Bacci, Dicpinigaitis, & Vernon, 2020; Spinou & Birring, 2014). 
Additionally, objective measures may be unable to measure aspects of cough that have a 
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legitimate impact on the individual, such as cough severity or disruption (Faruqi, Thompson, 
Wright, Sheedy, & Morice 2011; McCrory, Coeytaux, Yancy, & Schmit 2013; Spinou & Birring, 
2014). Subjective outcome measures are commonly used by researchers investigating chronic 
cough to measure severity and frequency. However, most severity and frequency outcome 
measures used in chronic cough research fail to be validated or standardized (Boulet et al., 2015; 
Kelsall et al., 2011; Lee et al., 2012; McCrory et al., 2013).  
 Accurate and responsive outcome measures are necessary for the determination of 
treatment effectiveness. Without valid or repeatable outcome measures, the confidence of 
research examining treatments for chronic cough remains uncertain, and the impact on patients is 
unclear. The purpose of this review is to evaluate the currently available outcome measures used 
in order to determine optimal protocols needed to ascertain the efficacy of chronic cough 
treatment. 
Outcome Measures 
Subjective Measures 
 Until recently, only subjective parameters were available to researchers investigating 
outcomes of chronic cough treatment. Subjective tools used to measure cough outcomes include 
visual analog scales (VAS), cough scores, and health-related quality-of-life questionnaires 
(HRQOL) (Schmit et al., 2013; Decalmer et al., 2007; Birring & Spinou, 2015; Boulet et al., 
2015; Marsden et al., 2008). Both cough severity VAS and HRQOL questionnaires can be easily 
applied in clinical practice and are frequently used by investigators as outcome measures in 
research (Birring & Spinou, 2015). The scope of subjective measures includes patient perception 
of cough intensity, frequency, cough severity, quality-of-life, and response to treatment. 
However, not all subjective measures have been validated, and may, therefore, be prone to bias 
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as they vary with the temperament of the participant, the patient's ability to recall symptoms, and 
the participant's expectations of treatment (Kelsall et al., 2011; Marsden et al., 2008). 
 Cough severity visual analog scales (VAS). A subjective tool, visual analog scales (VAS) have 
been adapted to measure cough severity. With cough severity VAS, the patient reports a rating 
by marking on a horizontal or vertical line that ranges from "no cough" to "worst cough" 
(Marsden et al., 2008). VAS may be given in paper or electronic form and may provide 
complementary data to cough-specific health-related quality-of-life questionnaires. Additionally, 
VAS has been shown to be a highly responsive tool (Birring & Spinou, 2015; Faruqi et al., 
2011). However, VAS has not been psychometrically tested or well-researched, lacking a 
minimally important difference (MID) for chronic cough (although a 17mm MID has been 
reported by researchers for acute cough) (Boulet et al., 2015; Spinou & Birring, 2014). There is 
insufficient strength of evidence for VAS validity and repeatability (Boulet et al., 2015; McCrory 
et al., 2013). The American College of Chest Physicians (CHEST) guidelines recommend VAS 
scales be standardized to address the issue of validity. Standardization of the VAS includes the 
use of a 100mm closed-end scale with the word "cough" on both ends indicated with 
perpendicular lines (Boulet et al., 2015). 
 Cough severity measures. Cough severity may be measured via the Cough Severity Diary 
(CSD) or through cough scores (also known as Cough Symptom Scores or Cough Severity 
Scores). The Cough Severity Diary is a seven-item diary wherein individuals rate their cough 
severity across three domains (frequency, intensity, and disruptiveness) across a 24-hour period. 
The scores on the three domains range from 0-10 (0=never to 10=constantly), with the total score 
taken as an average of the three domains. A higher score signifies a greater cough severity 
(Vernon, Kline Leidy, Nacson, & Nelsen, 2010; Nguyen et al., 2020). Nguyen et al. (2020) 
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found that the CSD was valid, reliable, and responsive to change with a preliminary clinically 
meaningful difference of a ⩾ 1.3 score change. A more diverse sample size is needed to confirm 
the clinically meaningful difference and validity of the measure. 
 Cough scores, Cough Symptom Scores, or Cough Severity Scores are two-part 
questionnaires that differentiate between both day and night cough (Birring & Spinou, 2015: 
Spinou & Birring, 2014). The cough scores use a numeric scoring system (0-5) (Hamutcu, 
Francis, Karakoc, & Bush, 2002; Hsu et al., 1994; Marsden et al., 2008). Each number is 
followed by a brief description (ex. Hsu et al. (1994): "(0) no cough during the day, (1) cough for 
one short period, (2) cough for more than two short periods (3) frequent coughing, which did not 
interfere with usual daytime activities (4) frequent coughing, which did interfere with usual 
daytime activities, and (5) distressing cough most of the day"). The descriptions are altered to 
match night/sleep disturbance for the nighttime part of the questionnaire. Cough scores have 
application in a busy clinic because they are easy and quick to administer. However, cough 
scores are not validated or standardized and are subject to bias (Kelsall et al., 2011). 
Furthermore, the minimally important difference for cough severity scores is unknown (Spinou 
& Birring, 2014). 
 Health-related quality-of-life questionnaires (HRQoL). Health-related quality-of-life 
(HRQoL) questionnaires measure the patient's perception of the impact of health and disease on 
several domains (French et al., 2003). QoL questionnaires range from specific to non-specific, 
focusing on general health, or domains impacted specifically by cough (Irwin et al., 2006). 
Cough specific questionnaires include the Leicester Cough Questionnaire (LCQ), Cough-
Specific Quality-of-Life Questionnaire (CLQC), Chronic Cough Impact Questionnaire, Cough-
Specific Quality-of-Life Questionnaire (CQLQ), Pediatric Cough Questionnaire (PCQ), and 
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Adverse Cough Outcome Survey (ACOS) (McCrory et al., 2013; Schmit et al., 2013). Non-
specific HRQoL questionnaires are not recommended for clinical research of chronic cough. 
Instead, The American College of Chest Physicians (CHEST) cough guidelines recommend 
cough-specific HRQoL questionnaires as the measurement of cough's impact on patients, as they 
are validated and reliable (Boulet et al., 2015). 
 Researchers often use the Leicester Cough Questionnaire (LCQ) for cough-specific 
quality-of-life. Composed of 19 items, the LCQ measures physical, psychological, and social 
domains. Patient score within the domains ranges 1-7, with a total score that falls between 3-21. 
A higher score demonstrates a better health status (Lee et al., 2012). For its preliminary 
validation, the LCQ underwent item generation using preexisting HRQoL questionnaires, item 
reduction via patient rating (1-5) for the importance of each item and analysis under the clinical 
impact factor method. Additionally, repeatability and responsiveness were tested and confirmed 
(Birring et al., 2003). The Leister cough questionnaire is brief. On average, the LCQ takes five 
minutes for the patient to complete (Birring et al., 2003; Spinou & Birring, 2014). 
 Correlations between cough-specific quality-of-life questionnaires with objective 
measures are well-researched. For instance, a fair to moderate correlation was found between the 
LCQ and the Cough-Specific Quality-of-Life Questionnaire (CLQC), suggesting their 
interchangeability (McCrory et al., 2013; Schmit et al., 2013). However, cough specific QoL 
measures were not designed to measure cough severity directly. They may be, therefore, unable 
to fully capture the impact of cough severity for individuals with chronic cough (Vernon et al., 
2010). 
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Objective Measures 
 In response to the lack of objective methods capable of quantifying cough frequency for 
chronic cough, researchers have designed objective outcome measure tools. (Decalmer et al., 
2007; Lee et al., 2012). Objective cough counting has become more accessible in recent years, 
with programs such as the Automated Device for Asthma Monitoring and Management 
(ADAMM), which allow users to track their disease state in real-time through an app on their 
phone (Sterling, Rhee, & Bocko, 2014). The scope of objective measures includes cough 
frequency and cough reflex sensitivity. Moreover, a study by Kelsall et al. (2011) found that 
objective measures are useful for the examination of chronic cough by lowering the sample size 
needed to demonstrate statistically significant results in parallel or cross over designs. 
 Cough counting. Objective cough measures include ambulatory measures of cough such 
as the Leicester Cough Monitor (LCM) or custom-built cough recorders, like those used by 
Decalmer et al. (2007) and Kelsall et al. (2011). Both video recording and audio may be used to 
count cough objectively. Cough counters, however, are currently unable to describe aspects of 
cough that may significantly impact a patient, such as cough severity or quality-of-life. 
 Objective cough counting ranges from automated (such as the LCM) to manual cough 
counting (used by the VitaloJack). Both manual cough counters and automated cough counts 
have been found by researchers to correlate well (Hamutcu et al., 2002; Hsu et al., 1994). 
Researchers Hsu et al. (1994) were able to demonstrate a strong correlation between manual and 
audio cough counts with EMG signals. Nevertheless, while there is a strong correlation between 
the two methods, manual cough counts can be difficult to implement for large data sets as they 
are time-consuming and labor inducive, and therefore limit the feasibility of their application 
(Decalmer et al., 2007; Smith et al., 2006). 
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 Cough frequency may be quantified through time spent coughing (cough seconds), total 
cough counts, or cough epochs (also known as cough bouts) (Marsden et al., 2008; Kelsall et at., 
2008). Cough seconds and total cough count qualification measures are considered to be 
interchangeable due to their sufficient correlation and moderate agreement with cough-related 
quality-of-life questionnaires and cough severity scores. Cough epochs demonstrated a lower 
correlation, and therefore serve as a weaker alternative (Kelsall et al., 2008). 
 Although most cough frequency recorders measure 24-hour periods, shorter cough 
duration recordings of four hours and six hours were found by Lee et al. (2012) to correlate well 
with 24-hour recordings and subjective measures. Birring (2011) reported that 80% of patient's 
coughs occur during the daytime, suggesting that shorter duration cough monitoring may be 
sufficient in demonstrating therapy effectiveness. Currently, the most useful duration for cough 
monitoring is unknown (Boulet et al., 2015). 
 A cough counter commonly used in chronic cough research is the Leicester Cough 
Monitor (LCM). The LSM is a semi-automated ambulatory (audio) device that uses computer 
software to analyze 24-hour MP3 recordings. These recordings take an average of one hour to 
process (Birring et al., 2003; Birring & Spinou 2015; Chamberlain et al., 2017; Sterling et al., 
2014). LCM measures cough frequency with a sensitivity and specificity of 91% and 99%, 
respectively, and has been found to be repeatable (Birring et al., 2008; Birring & Spinou, 2015; 
Lee et al., 2012). As a barrier to its use in research and clinical application, the LCM is not 
commercially available, making analysis costly. 
 While cough counting devices are objectively able to demonstrate reduction of cough 
during clinical trials, it is currently unknown if audio cough counters can accurately account for 
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cough severity. CHEST guidelines recommend cough counting be used only to assess cough 
frequency and not cough severity (Boulet et al., 2015). 
 Cough challenge testing. Cough challenge testing, also known as cough sensitivity testing 
or cough reflex sensitivity testing, examines the sensitivity of an individual's cough reflex. 
Typically, this is accomplished using increasing (or doubling) doses of citric acid or capsaicin 
and placebo doses of saline given in vapor form through a nebulizer. Citric acid or capsaicin 
serve as cough stimulants, inducing coughing (Decalmer et al., 2007). Researchers record doses 
that trigger two coughs (C2) and five coughs (C5) within one minute as an individual's baseline 
sensitivity (Decalmer et al., 2007; Marsden et al., 2008). Of objective testing, cough challenge 
testing is the most commonly used. Researchers have found cough challenge testing to be 
reproducible in patients (Birring, 2011; Spinou & Birring, 2014). However, cough challenge 
testing has been found by some studies to be unreliable in discriminating patients with chronic 
cough from healthy patients, possibly due to the protocols that terminate challenge testing after 
the C5 endpoint (Hilton et al., 2013; Spinou & Birring, 2014). Additionally, other studies report 
that cough challenge testing may be unable to detect the effect of antitussive therapy if the 
therapy targets a different reflex pathway (Birring, 2010). 
Correlation Between Objective Cough Counting and Subjective Measures. 
 Several studies examined the correlation between cough measures, with varying results. 
The correlation between subjective measures and objective cough frequency counting tools 
varied by subjective instrument type and range, from no correlation to a moderate correlation. 
Unvalidated forms of subjective outcome measures, such as the VAS and cough scores reflected 
greater variability than validated tools such as the LCQ (a cough specific QoL tool). 
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 Quality-of-life questionnaires. A moderate to strong correlation between cough counting 
tools and subjective outcome measures and QoL questionnaires was demonstrated by several 
studies (Decalmer et al., 2007; Faruqi et al., 2011; Kelsall et al., 2011; Lee et al. 2011; Marsden 
et al., 2008; Schmit et al., 2013). Lee et al. (2011) found a moderate correlation between 24-h 
and 4-h recordings with HRQoL questionnaires. When compared to other subjective measures, 
Marsden et al. (2008) found the closest relation between cough counts and the LCQ. 
Additionally, Decalmer et al. (2007) and Faruqi et al. (2011) found the strongest correlation 
between the LCQ and manual cough counting measures, with a moderate correlation (Decalmer 
et al. (2007) r=-0.62, P<0.001, and Faruqi et al. (2011) r= -0.6, P < 0.001). Kelsall et al. (2011) 
were able to demonstrate a response to change via both cough rates and LCQ. 
 Cough severity visual analog scale (VAS). Researchers found a weak to strong 
correlation between VAS and cough frequency, varying between total VAS score, day VAS 
score, and night VAS score (Chamberlain et al., 2017; Decalmer et al., 2007; Faruqi et al., 2011; 
Kelsall et al., 2011; Key, Holt, Hamilton, Smith, & Earis, 2010; Lee et al., 2012; Marsden et al., 
2008; Schmit et al., 2013). Key et al. (2010) found a strong correlation between VAS scores and 
cough counts with a day score of Pearson's r = 0.80 and p < 0.001, and a night score of r = 0.71, 
p = 0.001. In their study, Lee et al. (2012) reported a moderate correlation of VAS to 24-hour 
and 4-hour cough frequency recordings. Decalmer et al. (2007) found a moderate positive 
correlation between VAS scores and objective cough measure for both day and night (Pearson's 
r=0.46, p<0.001 for day scores and Pearson's r=0.61, p<0.001). During their single-blinded 
randomized-controlled trial investigating physiotherapy, speech and language therapy 
intervention (PSALTI), Chamberlain et al. (2017) found a more significant reduction in VAS 
score within the PSALTI group. However, Marsden et al. (2008) found only a weak correlation 
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between day and night VAS scores and cough frequency rates (Pearson's r=0.32, p=.002 for day 
scores, r=.43, p=.003 for night scores), and Kelsall et al. (2011) found that overall decrease in 
cough frequency did not correlate with changes in day VAS scores. Furthermore, Faruqi et al. 
(2011) found a weaker degree of reproducibility of VAS when compared to the LCQ. 
 Cough severity measures. Cough scores and the Cough Severity Diary (CSD) 
demonstrated anywhere from no correlation to a strong correlation with objective frequency 
counts, varying by study and tool used (Hsu et al., 1994; Marsden et al.; 2008; Nguyen et al., 
2020; Schmit et al., 2013; Smith, Owen, Earis, & Woodcock, 2006). Only Nguyen et al. (2020) 
analyzed the Cough Severity Diary with objective cough counts. Nguyen et al. (2020) compared 
awake cough counts with the change in CSD score to assess the responsiveness of the 
instrument, finding a strong-to-moderate correlation between the two measures.  
 For cough scores, Hsu et al. (1994) found a significant correlation between daytime 
cough frequency and cough scores (p<0.01). These cough score findings were more strongly 
correlated for patients with chronic cough than patients with asthma. However, Marsden et al. 
(2008) only found weak correlations between both day and night cough scores and cough rates 
(Pearson's r=0.32, p<.002 for the day, and r=0.44, p<.001 for the night). Decalmer et al. (2007) 
found a moderate correlation between cough scores and cough frequency data with day r =0.50, 
p<0.00, and a night r =0.55, p<0.001. 
 Smith et al. (2006) found no correlation between night cough scores and objective 
measures, and Hamutcu et al. (2002) found no correlation between cough scores and a cough 
counting recording device (the LR 100) despite a measured reduction in cough frequency. 
Furthermore, change in cough frequency was not reflected by either day or night cough scores in 
the study by Kelsall et al. (2011) (P=.05; Wilcoxon, Z = -1.96 for day, and P=.04; Wilcoxon, Z= 
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-2.03 for night). Smith et al. (2006) found no correlation between the measured reduction in 
cough counts and cough scores in either the placebo or codeine group. 
Correlation Between Cough Challenge Testing and Other Measures 
 Cough frequency rate decreases were reflected by an increase in cough challenge testing 
data in a study by Faruqi et al. (2011). However, cough sensitivity did not correlate well with 
subjective outcome measures. Marsden et al. (2015) found a weak correlation between daytime 
cough rates for (C2) but no correlation for (C5) while Decalmer et al. (2007) and Chang, Phelan, 
Robertson, Roberts, and Sawyer (2003) found an inverse correlation between daytime cough 
rates and logC5 (Decalmer et al. (2007) reported a Pearson's r= - 0.45, p<0.001, and Chang et al. 
(2003) reported an r= - 0.38, p=0.03). Furthermore, Chamberlain et al. (2017) found no 
significant difference between PSALTI group and control group for C2 or C5, suggesting cough 
challenge testing's inability to differentiate between subjects. The PSALTI group, however, 
demonstrated a reduction in C5 after treatment that was not reflected by the control group, 
suggesting cough challenge testing may indicate a response to change. 
Discussion 
Clinical Implications 
 The purpose of this review is to evaluate optimal outcome measures necessary to 
determine the effectiveness of treatment for chronic cough. Currently, most outcome measures 
used in research fail to be validated or standardized. Overall, the poor to moderate level of 
correlation between objective and subjective tools suggests that the different outcome measures 
are not interchangeable and assess different constructs. Furthermore, although some studies 
found an objective decrease in cough counts, the reduction was not always reflected via 
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subjective outcome measures. This lack of correlation indicates that a decrease in cough counts 
may not be the sole factor in dictating a patient's perception of cough impact. 
 Subjective tools measure a wider scope of constructs than objective cough frequency 
counting or cough challenge testing because they are able to demonstrate patient perception of 
intensity, severity of cough, and impact on various domains. However, because of subjective 
measures' overall lack of standardization, researchers are unable to rely on VAS and cough 
scores alone. More validated measures, such as the Cough Severity Diary (CSD) and Leicester 
Cough Questionnaire (LCQ) showed the greatest correlation with objective cough counting and 
indicated responsiveness to change, suggesting that they may better measure aspects of cough 
that impact a patient’s perception of response to treatment. 
 Although objective measures fail to account for all aspects of cough that impact patients, 
the use of cough frequency counting in combination with subjective measures increases the 
validity of treatment findings. Therefore, in order to obtain a holistic view of cough, researchers 
should use data from both subjective and objective instruments when determining cough 
treatment outcomes. 
Future Implications 
 No device currently measures all domains affected by cough. A device with the ability to 
measure cough severity/intensity, cough disturbance, and cough frequency might account for the 
variance between objective and subjective measures. Such a device would be beneficial for 
future studies and clinical trials and may account for the lack of correlation between measures. 
Furthermore, additional research on the standardization of subjective measures such as VAS, 
cough scores, and the CSD is needed to determine the validity of their data. Because of the ease 
of use in a clinical setting, VAS, cough scores, and the CSD should be further researched. 
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